New combo therapy aims to save esophagus in cancer patients
NCT ID NCT05667298
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This early-phase study tests whether combining endoscopic tumor removal with chemotherapy, radiation, or immunotherapy is safe for people with early-stage esophageal cancer who cannot or choose not to have surgery. The goal is to preserve the esophagus while controlling the cancer. Only 11 participants are enrolled to check for serious side effects and see if the approach is feasible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CancerCare Manitoba
Winnipeg, Manitoba, R3E 0V9, Canada
Conditions
Explore the condition pages connected to this study.